Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
High-dose Albumin in Advanced Cirrhosis
NCT05867602Phase 2Recruiting
- Sponsor
- Baylor College of Medicine
- Start
- Mar 2019
- Primary completion
- Mar 2027
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
A Phase 2 trial of albumin (human) in Liver cirrhosis (LC), ascites, sponsored by Baylor College of Medicine. Started Mar 2019; status: recruiting.
02
Drugs
albumin (human)
03
Conditions
Liver cirrhosis (LC)ascites
Beyond the preview
Go deeper on NCT05867602.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05867602.